Table 1 Characteristics of patients who were offered first-line chemotherapy, whochose ASC or chemotherapy
Chose chemotherapy | Chose ASC | p | |
|---|---|---|---|
Total (n = 139) | 93 (66.9) | 46 (33.1) | |
Sex, n (%) | |||
Male | 83 (89.2) | 35 (76.1) | 0.041 |
Female | 10 (10.8) | 11 (23.9) | |
Laterality, n (%) | |||
Right | 54 (58.1) | 27 (58.7) | |
Left | 39 (41.9) | 19 (41.3) | |
0.943 | |||
Age, mean (SD) | |||
68.4 (6.36) | 74.4 (7.35) | <0.001 | |
Performance status, n (%) | |||
0 | 40 (43.0) | 8 (17.4) | |
1 | 48 (51.6) | 32 (69.6) | |
2 | 5 (5.4) | 6 (13.0) | |
0.005 | |||
Histology, n (%) | |||
Epithelioid | 63 (67.7) | 36 (78.3) | |
Sarcomatoid | 15 (16.1) | 6 (13.0) | |
Biphasic | 9 (9.7) | 1 (2.2) | |
Desmoplastic | 2 (2.2) | 1 (2.2) | |
Not specified | 4 (4.3) | 2 (4.4) | |
0.540 | |||
IMIG tumour stage, n (%) | |||
IA | 28 (30.1) | 15 (32.6) | |
IB | 6 (6.5) | 0 | |
II | 7 (7.5) | 3 (6.5) | |
IIIA | 0 | 0 | |
IIIB | 30 (32.2) | 13 (28.2) | |
IV | 10 (10.75) | 7 (15.2) | |
Not documented | 12 (12.9) | 8 (17.4) | |
0.543 | |||
Symptoms, n (%) | |||
Chest pain | 38 (40.9) | 22 (47.8) | 0.435 |
Breathlessness | 75 (80.7) | 39 (84.8) | 0.550 |
Cough | 42 (45.1) | 18 (39.1) | 0.499 |
Systemic symptoms (sweats, weight loss, fatigue) | 37 (39.8) | 22 (47.8) | 0.367 |
Blood tests, median (IQR) | |||
Haemoglobin, g/dL | 138 (126-150) | 132.5 (121-149) | 0.263 |
Neutrophils, ×109/L | 5.73 (4.80-7.00) | 5.84 (4.28-7.00) | 0.729 |
Lymphocytes, ×109/L | 1.6 (1.15-2.15) | 1.32 (1.00-1.94) | 0.076 |
Albumin, g/L | 35 (31-38) | 34 (30-38) | 0.456 |
Neutrophil Lymphocyte Ratio (NLR) | 4.00 (2.73-5.38) | 4.18 (3.09-6.38) | 0.255 |